Molecular Analysis of a Mutated FSH Receptor Detected in a Patient with Spontaneous Ovarian Hyperstimulation Syndrome

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Uchida, Sayaka ^a   Uchida, Hiroshi ^a   Maruyama, Tetsuo ^a   Kajitani, Takashi ^a   Oda, Hideyuki ^a   Miyazaki, Kaoru ^a   Kagami, Maki ^a   Yoshimura, Yasunori ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; FOLLITROPIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44;

ABDOMINAL SCINTISCANNING; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BIOLOGICAL ACTIVITY; CASE REPORT; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; FSHR GENE; GENE; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OVARY HYPERSTIMULATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRUS ONCOGENE;

ADULT; AMINO ACID SUBSTITUTION; CELL LINE; FEMALE; FOLLICLE STIMULATING HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM PROTEINS; OVARIAN HYPERSTIMULATION SYNDROME; PHOSPHATIDYLINOSITOL 3-KINASES; PITUITARY NEOPLASMS; PROTEIN-TYROSINE KINASES; RECEPTORS, FSH;

EID: 84884159794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075478     Document Type: Article

References (42)

1. Binder H, Dittrich R, Einhaus F, Krieg J, Müller A, et al. (2007) Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis. Int J Fertil Womens Med 52: 11-26. PubMed: 17987884.
2. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, et al. (2006) Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril 85: 112-120. doi:10.1016/j.fertnstert.2005.07.1292. PubMed: 16412740.
3. Rotmensch S, Scommegna A, (1989) Spontaneous ovarian hyperstimulation syndrome associated with hypothyroidism. Am J Obstet Gynecol 160: 1220-1222. doi:10.1016/0002-9378(89)90196-8. PubMed: 2729396.
4. Zalel Y, Katz Z, Caspi B, Ben-Hur H, Dgani R, et al. (1992) Spontaneous ovarian hyperstimulation syndrome concomitant with spontaneous pregnancy in a woman with polycystic ovary disease. Am J Obstet Gynecol 167: 122-124. doi:10.1016/S0002-9378(11)91642-1. PubMed: 1442911.
5. Costagliola S, Urizar E, Mendive F, Vassart G, (2005) Specificity and promiscuity of gonadotropin receptors. Reproduction 130: 275-281. doi:10.1530/rep.1.00662. PubMed: 16123234.
6. De Leener A, Montanelli L, Van Durme J, Chae H, Smits G, et al. (2006) Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab 91: 555-562. PubMed: 16278261.
7. Meduri G, Bachelot A, Cocca MP, Vasseur C, Rodien P, et al. (2008) Molecular pathology of the FSH receptor: new insights into FSH physiology. Mol Cell Endocrinol 282: 130-142. doi:10.1016/j.mce.2007.11.027. PubMed: 18248882.
8. Djerassi A, Coutifaris C, West VA, Asa SL, Kapoor SC, et al. (1995) Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrinol Metab 80: 591-594. doi:10.1210/jc.80.2.591. PubMed: 7852525.
9. Tashiro H, Katabuchi H, Ohtake H, Kaku T, Ushio Y, et al. (1999) A follicle-stimulating hormone-secreting gonadotroph adenoma with ovarian enlargement in a 10-year-old girl. Fertil Steril 72: 158-160. doi:10.1016/S0015-0282(99)00197-1. PubMed: 10428166.
10. Murata Y, Ando H, Nagasaka T, Takahashi I, Saito K, et al. (2003) Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma. J Clin Endocrinol Metab 88: 1988-1993. doi:10.1210/jc.2002-021820. PubMed: 12727942.
11. Mor E, Rodi IA, Bayrak A, Paulson RJ, Sokol RZ, (2005) Diagnosis of pituitary gonadotroph adenomas in reproductive-aged women. Fertil Steril 84: 757. PubMed: 16169418.
12. Catargi B, Felicie-Dellan E, Tabarin A, (1999) Comment on gonadotroph adenoma causing ovarian hyperstimulation. J Clin Endocrinol Metab 84: 3404. doi:10.1210/jc.84.9.3404. PubMed: 10487722.
13. Pentz-Vidovíc I, Skorić T, Grubisić G, Korsíc M, Ivicevic-Bakulic T, et al. (2000) Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulation. Eur J Endocrinol 143: 607-614. doi:10.1530/eje.0.1430607. PubMed: 11078984.
14. Gryngarten MG, Braslavsky D, Ballerini MG, Ledesma J, Ropelato MG, et al. (2010) Spontaneous ovarian hyperstimulation syndrome caused by a follicle-stimulating hormone-secreting pituitary macroadenoma in an early pubertal girl. Horm Res Paediatr 73: 293-298. doi:10.1159/000284395. PubMed: 20215777.
15. Cooper O, Geller JL, Melmed S, (2008) Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma. Nat Clin Pract Endocrinol Metab 4: 234-238. doi:10.1038/ncpneph0778. PubMed: 18268519.
16. Castelo-Branco C, del Pino M, Valladares E, (2009) Ovarian hyperstimulation, hyperprolactinaemia and LH gonadotroph adenoma. Reprod Biomed Online 19: 153-155. doi:10.1016/S1472-6483(10)60065-X. PubMed: 19712547.
17. Christin-Maitre S, Rongières-Bertrand C, Kottler ML, Lahlou N, Frydman R, et al. (1998) A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma. J Clin Endocrinol Metab 83: 3450-3453. doi:10.1210/jc.83.10.3450. PubMed: 9768644.
18. Välimäki MJ, Tiitinen A, Alfthan H, Paetau A, Poranen A, et al. (1999) Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone in 28-year-old woman. J Clin Endocrinol Metab 84: 4204-4208. doi:10.1210/jc.84.11.4204. PubMed: 10566673.
19. Shimon I, Rubinek T, Bar-Hava I, Nass D, Hadani M, et al. (2001) Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 86: 3635-3640. doi:10.1210/jc.86.8.3635. PubMed: 11502789.
20. Castelbaum AJ, Bigdeli H, Post KD, Freedman MF, Snyder PJ, (2002) Exacerbation of ovarian hyperstimulation by leuprolide reveals a gonadotroph adenoma. Fertil Steril 78: 1311-1313. doi:10.1016/S0015-0282(02)04342-X. PubMed: 12477530.
21. Roberts JE, Spandorfer S, Fasouliotis SJ, Lin K, Rosenwaks Z, (2005) Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma. Fertil Steril 83: 208-210. doi:10.1016/j.fertnstert.2004.06.061. PubMed: 15652911.
22. Maruyama T, Masuda H, Uchida H, Nagashima T, Yoshimura Y, (2005) Follicle stimulating hormone-secreting pituitary microadenoma with fluctuating levels of ovarian hyperstimulation. Obstet Gynecol 105: 1215-1218. doi:10.1097/01.AOG.0000141554.50747.16. PubMed: 15863587.
23. Sugita T, Seki K, Nagai Y, Saeki N, Yamaura A, et al. (2005) Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman. Gynecol Obstet Invest 59: 138-143. doi:10.1159/000083087. PubMed: 15637432.
24. Ghayuri M, Liu JH, (2007) Ovarian hyperstimulation syndrome caused by pituitary gonadotroph adenoma secreting follicle-stimulating hormone. Obstet Gynecol 109: 547-549. doi:10.1097/01.AOG.0000247316.60573.4a. PubMed: 17267890.
25. Baba T, Endo T, Kitajima Y, Kamiya H, Moriwaka O, et al. (2009) Spontaneous ovarian hyperstimulation syndrome and pituitary adenoma: incidental pregnancy triggers a catastrophic event. Fertil Steril 92390:: e391-e393. PubMed: 19356755.
26. Kihara M, Sugita T, Nagai Y, Saeki N, Tatsuno I, et al. (2006) Ovarian hyperstimulation caused by gonadotroph cell adenoma: a case report and review of the literature. Gynecol Endocrinol 22: 110-113. doi:10.1080/09513590600581665. PubMed: 16603438.
27. Galway AB, Hsueh AJ, Daneshdoost L, Zhou MH, Pavlou SN, et al. (1990) Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone. J Clin Endocrinol Metab 71: 907-912. doi:10.1210/jcem-71-4-907. PubMed: 2119391.
28. Borgato S, Persani L, Romoli R, Cortelazzi D, Spada A, et al. (1998) Serum FSH bioactivity and inhibin levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas. J Endocrinol Invest 21: 372-379. PubMed: 9699129.
29. Kajitani T, Liu S, Maruyama T, Uchida H, Sakurai R, et al. (2008) Analysis of serum FSH bioactivity in a patient with an FSH-secreting pituitary microadenoma and multicystic ovaries: A case report. Hum Reprod 23: 435-439. PubMed: 18056718.
30. Ramensky V, Bork P, Sunyaev S, (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30: 3894-3900. doi:10.1093/nar/gkf493. PubMed: 12202775.
31. Ng PC, Henikoff S, (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812-3814. doi:10.1093/nar/gkg509. PubMed: 12824425.
32. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311. doi:10.1093/nar/29.1.308. PubMed: 11125122.
33. Hirakawa M, Tanaka T, Hashimoto Y, Kuroda M, Takagi T, et al. (2002) JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res 30: 158-162. doi:10.1093/nar/30.1.158. PubMed: 11752280.
34. Haga H, Yamada R, Ohnishi Y, Nakamura Y, Tanaka T, (2002) Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism. J Hum Genet 47: 605-610. doi:10.1007/s100380200092. PubMed: 12436197.
35. Wayne CM, Fan HY, Cheng X, Richards JS, (2007) Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol Endocrinol 21: 1940-1957. doi:10.1210/me.2007-0020. PubMed: 17536007.
36. Hunzicker-Dunn ME, Lopez-Biladeau B, Law NC, Fiedler SE, Carr DW, et al. (2012) PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells. Proc Natl Acad Sci U S A 109: E2979-E2988. doi:10.1073/pnas.1205661109. PubMed: 23045700.
37. Simoni M, Gromoll J, Nieschlag E, (1997) The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18: 739-773. doi:10.1210/er.18.6.739. PubMed: 9408742.
38. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, et al. (2003) Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 349: 760-766. doi:10.1056/NEJMoa030064. PubMed: 12930928.
39. Lussiana C, Guani B, Restagno G, Rovei V, Menato G, et al. (2009) Ovarian hyper-stimulation syndrome after spontaneous conception. Gynecol Endocrinol 25: 455-459. doi:10.1080/09513590902898213. PubMed: 19499413.
40. Beshay VE, Beshay JE, Halvorson LM, (2007) Pituitary tumors: diagnosis, management, and implications for reproduction. Semin Reprod Med 25: 388-401. doi:10.1055/s-2007-984745. PubMed: 17710735.
41. Genua M, Pandini G, Sisci D, Castoria G, Maggiolini M, et al. (2009) Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells. Cancer Res 69: 7270-7277. doi:10.1158/0008-5472.CAN-09-0088. PubMed: 19738069.
42. Lussiana C, Guani B, Mari C, Restagno G, Massobrio M, et al. (2008) Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv 63: 785-795. doi:10.1097/OGX.0b013e31818957eb. PubMed: 19017414.